1. Home
  2. NBIX vs LECO Comparison

NBIX vs LECO Comparison

Compare NBIX & LECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • LECO
  • Stock Information
  • Founded
  • NBIX 1992
  • LECO 1895
  • Country
  • NBIX United States
  • LECO United States
  • Employees
  • NBIX N/A
  • LECO N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • LECO Industrial Machinery/Components
  • Sector
  • NBIX Health Care
  • LECO Industrials
  • Exchange
  • NBIX Nasdaq
  • LECO Nasdaq
  • Market Cap
  • NBIX 11.6B
  • LECO 11.3B
  • IPO Year
  • NBIX 1996
  • LECO N/A
  • Fundamental
  • Price
  • NBIX $120.69
  • LECO $207.27
  • Analyst Decision
  • NBIX Buy
  • LECO Buy
  • Analyst Count
  • NBIX 21
  • LECO 7
  • Target Price
  • NBIX $168.35
  • LECO $233.00
  • AVG Volume (30 Days)
  • NBIX 1.6M
  • LECO 303.9K
  • Earning Date
  • NBIX 02-06-2025
  • LECO 02-13-2025
  • Dividend Yield
  • NBIX N/A
  • LECO 1.45%
  • EPS Growth
  • NBIX 33.20
  • LECO N/A
  • EPS
  • NBIX 3.29
  • LECO 8.15
  • Revenue
  • NBIX $2,355,300,000.00
  • LECO $4,008,670,000.00
  • Revenue This Year
  • NBIX $16.29
  • LECO $3.45
  • Revenue Next Year
  • NBIX $16.90
  • LECO $4.94
  • P/E Ratio
  • NBIX $36.68
  • LECO $25.43
  • Revenue Growth
  • NBIX 24.81
  • LECO N/A
  • 52 Week Low
  • NBIX $110.95
  • LECO $169.51
  • 52 Week High
  • NBIX $157.98
  • LECO $261.13
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 35.76
  • LECO 58.17
  • Support Level
  • NBIX $113.00
  • LECO $189.19
  • Resistance Level
  • NBIX $118.61
  • LECO $217.80
  • Average True Range (ATR)
  • NBIX 4.28
  • LECO 4.78
  • MACD
  • NBIX -2.22
  • LECO 1.72
  • Stochastic Oscillator
  • NBIX 18.81
  • LECO 58.29

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About LECO Lincoln Electric Holdings Inc.

Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. The firm's portfolio of products includes arc-welding solutions, plasma and oxy-fuel cutting systems, and brazing and soldering alloys, as well as automation solutions. Lincoln Electric serves clients in the general fabrication, heavy industries, automotive, construction, shipbuilding, energy and process industries, among other end markets. Based in Cleveland, Ohio, Lincoln Electric has operations in 19 countries and has 11,000 employees worldwide. The company generated roughly $4.2 billion in sales in 2023.

Share on Social Networks: